北美人类白细胞抗原 (HLA) 检测市场预测至 2028 年 - 按产品和服务(试剂和耗材、仪器以及软件和服务)、技术(分子测定技术和非分子测定技术)划分的 COVID-19 影响和区域分析和最终用户(独立参考实验室、医院和移植中心等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 172    |    Report Code: BMIRE00025763    |    Category: Life Sciences

North America Human Leukocyte Antigen (HLA) Testing Market

北美人类白细胞抗原(HLA)检测市场预计将从2022年的3.2449亿美元增长到2028年的5.0472亿美元;预计 2022 年至 2028 年复合年增长率为 7.6%。

 

人类白细胞抗原 (HLA) 是存在于所有细胞表面的特殊蛋白质除红细胞外的人体组织。 HLA 检测在器官移植中具有重要应用,可推荐作为肾衰竭、慢性肝硬化和慢性心脏病等医学问题治疗的一部分。慢性疾病和器官衰竭的日益流行导致对器官移植手术以及 HLA 检测的高需求。移植前,进行 HLA 测试以检查患者和捐赠者之间的组织相容性,以避免移植物排斥。近年来,移植已成为一个成功的实践领域。各国政府正在采取措施,提高人们对器官捐献的必要性以及器官移植在某些治疗过程中的益处的认识。例如,器官采购和移植网络(OPTN)已经实施了一些策略来提高美国器官移植手术的数量。这些策略的重点是增加终末期器官疾病患者的器官和组织移植数量,改变当前的器官分布,并通过重新分配现有的器官储备来修改器官移植等候名单。此外,OPTN 采用了现成的策略来改善器官移植。这些创新策略包括优化使用从已故患者获得的器官[例如心源性死亡(DCD)或脑死亡捐献者捐献]、减少器官废弃、促进活体捐献以及提高潜在器官捐献授权率。因此,随着器官移植需求的不断增长,对HLA检测试剂盒和耗材的需求量也随之增加,从而推动了HLA检测市场的发展。

 

有了新功能和技术,供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会在预测期内推动北美人类白细胞抗原 (HLA) 检测市场实现显着的复合年增长率。

 

北美人类白细胞抗原(HLA) 到 2028 年测试市场收入及预测(百万美元)

 

  ;

 

北美人类白细胞抗原(HLA)检测市场细分

 

北美人类白细胞抗原 (HLA) 检测市场分为产品和检测市场。服务、技术、最终用户和国家/地区。基于产品和服务,市场分为试剂和服务耗材、仪器、软件和服务。从技术上来说,北美人类白细胞抗原(HLA)检测市场分为分子检测技术和非分子检测技术。分子检测技术细分为基于 PCR 的分子检测、基于测序的分子检测等。根据最终用户,市场分为独立参考实验室、医院和移植中心等。按国家/地区划分,北美人类白细胞抗原 (HLA) 检测市场分为美国、墨西哥和加拿大。

 

北美人类白细胞抗原(HLA) 测试市场—— 提及的公司

 

Thermo FISHER SCIENTIFIC INC.;护理Dx;凯杰;照明公司; Bio-Rad 实验室公司; TBG诊断有限公司; F. 霍夫曼拉罗什有限公司;宝生物公司; Luminex 公司;奥米克森公司;测序中心;组织遗传学有限责任公司; CD 基因组学;金塔拉生物科学公司;和 CREATIVE BIOLABS, INC. 是北美人类白细胞抗原 (HLA) 检测市场的主要公司之一。



North America Human Leukocyte Antigen (HLA) Testing Strategic Insights

Strategic insights for North America Human Leukocyte Antigen (HLA) Testing involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-human-leukocyte-antigen-hla-testing-market-strategic-framework.webp
Get more information on this report

North America Human Leukocyte Antigen (HLA) Testing Report Scope

Report Attribute Details
Market size in 2022 US$ 324.49 Million
Market Size by 2028 US$ 504.72 Million
Global CAGR (2022 - 2028) 7.6%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 产品和服务
  • 试剂及耗材
  • 仪器
  • 软件及服务
By 技术
  • 分子检测技术
  • 非分子检测技术
By 最终用户
  • 独立参考实验室
  • 医院和移植中心
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • THERMO FISHER SCIENTIFIC INC.
  • CareDx
  • QIAGEN
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • TBG Diagnostics Limited
  • F. HOFFMANN-LA ROCHE LTD.
  • Takara Bio Inc.
  • Luminex Corporation
  • Omixon Inc.
  • Get more information on this report

    North America Human Leukocyte Antigen (HLA) Testing Regional Insights

    The regional scope of North America Human Leukocyte Antigen (HLA) Testing refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-human-leukocyte-antigen-hla-testing-market-geography.webp
    Get more information on this report

    The List of Companies - North America Human Leukocyte Antigen (HLA) Testing Market

    1.  THERMO FISHER SCIENTIFIC INC.                            
    2. CareDx                                                                                
    3. QIAGEN                                                                                              
    4. Illumina, Inc.                                                                     
    5. Bio-Rad Laboratories, Inc.                                           
    6. TBG Diagnostics Limited                                                               
    7. F. HOFFMANN-LA ROCHE LTD.                                  
    8. Takara Bio Inc.                                                                  
    9. Luminex Corporation                                                    
    10. Omixon Inc.                                                                       
    11. The Sequencing Center                
    12. HistoGenetics LLC
    13. CD Genomics
    14. Quintara Biosciences
    15.  CREATIVE BIOLABS, INC. 
    Frequently Asked Questions
    How big is the North America Human Leukocyte Antigen (HLA) Testing Market?

    The North America Human Leukocyte Antigen (HLA) Testing Market is valued at US$ 324.49 Million in 2022, it is projected to reach US$ 504.72 Million by 2028.

    What is the CAGR for North America Human Leukocyte Antigen (HLA) Testing Market by (2022 - 2028)?

    As per our report North America Human Leukocyte Antigen (HLA) Testing Market, the market size is valued at US$ 324.49 Million in 2022, projecting it to reach US$ 504.72 Million by 2028. This translates to a CAGR of approximately 7.6% during the forecast period.

    What segments are covered in this report?

    The North America Human Leukocyte Antigen (HLA) Testing Market report typically cover these key segments-

  • 产品和服务 (试剂及耗材, 仪器, 软件及服务)
  • 技术 (分子检测技术, 非分子检测技术)
  • 最终用户 (独立参考实验室, 医院和移植中心)
  • What is the historic period, base year, and forecast period taken for North America Human Leukocyte Antigen (HLA) Testing Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Human Leukocyte Antigen (HLA) Testing Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in North America Human Leukocyte Antigen (HLA) Testing Market?

    The North America Human Leukocyte Antigen (HLA) Testing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • THERMO FISHER SCIENTIFIC INC.
  • CareDx
  • QIAGEN
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • TBG Diagnostics Limited
  • F. HOFFMANN-LA ROCHE LTD.
  • Takara Bio Inc.
  • Luminex Corporation
  • Omixon Inc.
  • The Sequencing Center
  • HistoGenetics LLC
  • CD Genomics
  • Quintara Biosciences
  • CREATIVE BIOLABS, INC.
  • Who should buy this report?

    The North America Human Leukocyte Antigen (HLA) Testing Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Human Leukocyte Antigen (HLA) Testing Market value chain can benefit from the information contained in a comprehensive market report.